Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London, UK.
J Cardiovasc Magn Reson. 2012 Jan 18;14(1):6. doi: 10.1186/1532-429X-14-6.
Pulmonary hypertension represents a group of conditions characterized by higher than normal pulmonary artery pressures. Despite improved treatments, outcomes in many instances remain poor. In recent years, there has been growing interest in the use of cardiovascular magnetic resonance (CMR) in patients with pulmonary hypertension. This technique offers certain advantages over other imaging modalities since it is well suited to the assessment of the right ventricle and the proximal pulmonary arteries. Reflecting the relatively sparse evidence supporting its use, CMR is not routinely recommended for patients with pulmonary hypertension. However, it is particularly useful in patient with pulmonary arterial hypertension associated with congenital heart disease. Furthermore, it has proven informative in a number of ways; illustrating how right ventricular remodeling is favorably reversed by drug therapies and providing explicit confirmation of the importance of the right ventricle to clinical outcome. This review will discuss these aspects and practical considerations before speculating on future applications.
肺动脉高压是一组以肺动脉压力高于正常为特征的病症。尽管治疗方法有所改善,但在许多情况下,结果仍然不佳。近年来,人们对心血管磁共振(CMR)在肺动脉高压患者中的应用越来越感兴趣。与其他成像方式相比,该技术具有某些优势,因为它非常适合评估右心室和近端肺动脉。反映出支持其使用的相对较少的证据,CMR 不常规推荐用于肺动脉高压患者。然而,它在患有与先天性心脏病相关的肺动脉高压的患者中特别有用。此外,它在许多方面都证明了其信息性;说明了药物治疗如何有利地逆转右心室重构,并明确证实了右心室对临床结果的重要性。在推测未来的应用之前,本综述将讨论这些方面和实际考虑因素。